Event Bringing Together National, Local Leaders in Cancer Research

This year’s symposium event, to be held on November 14, is designed to encourage collaborative research among various educational institutions and other organizations in Nevada, while providing national perspectives on research. Panelists for the event include Marian Waterman, PhD from UC Irvine and Comprehensive Cancer Centers’ Oscar B. Goodman, Jr., MD, PhD., with opening comments presented by Roseman University of Health Sciences President, Renee Coffman PhD, RPh.

Marian Waterman, PhD, is professor of microbiology and molecular genetics at the University of California, Irvine School of Medicine; Director of the Cancer Research Institute; and Deputy Director of the Chao Family Comprehensive Cancer Center at UC Irvine. Dr. Waterman will share insights into the importance of American Cancer Society-funded research and how it has impacted her work, provide an overview of the grant application process, and share her journey as a member of a peer review committee.

Oscar B. Goodman, Jr., MD, PhD, is a medical oncologist and physician-scientist at Comprehensive Cancers of Nevada and serves as Associate Professor of Internal Medicine at Roseman University College of Medicine. Dr. Goodman will speak about his work in translational clinical research in the areas of prostate cancer research. Key discussion points will include: understanding the shortcomings of androgen deprivation therapies; potential points and approaches to restoring sensitivity; and identifying the shortcomings of prostate cancer-directed cytotoxic therapies and considering novel therapeutic approaches to address these shortcomings.

Following the reception, local research projects will be displayed at an informal networking reception. All attendees are encouraged to stay and network with fellow researchers and faculty.


To attend the event, please RSVP to Dr. Coffman at rcoffman@roseman.edu.

To display research boards, please contact Sam Wise at sam.wise@cancer.org for an application, as space may be limited and is available on a first come, first served basis.


November 14, 2019 | 12:30 P.M. – 5:30 P.M.
Roseman University of Health Sciences
Summerlin Campus (click here for a map link)
One Breakthrough Way
Las Vegas, NV 89135


12:30 p.m. – Registration and Welcome reception
1:30 p.m. – Opening comments by Renee Coffman PhD, RPh
1:45 p.m. – 4:30 p.m. – Presentations by Dr. Waterman and Dr. Goodman
4:30-5:30 p.m. – Research showcase and reception
5:30-7:30 p.m. – We welcome you to join us for the CEOs Against Cancer reception


Marian Waterman, PhD

Dr. Waterman received her degree in biochemistry and biophysics from Oregon State in 1981 and her doctorate in physiology/pharmacology from UC San Diego in 1987. Dr. Waterman discovered one of the first gene regulators for a signaling pathway called “Wnt” – which is heavily implicated in multiple types of cancers.

She has devoted her research career to uncovering how Wnt signaling leads to colon cancer and how signaling directs stem cell behaviors in normal tissues. Throughout her career, Dr. Waterman has been supported by the American Cancer Society, starting as a post-doctoral fellow and then with research grant funding as an Assistant Professor.

Currently she is professor of microbiology and molecular genetics at the University of California, Irvine School of Medicine. Dr. Waterman serves as Director of the Cancer Research Institute, an Institute that operates as the basic science arm of the nationally designated UCI Chao Family Comprehensive Cancer Center.

She also serves as Deputy Director of the Chao Family Comprehensive Cancer Center at UC Irvine. In 2018, Dr. Waterman and two colleagues established an NCI-funded Center for Cancer Systems Biology (CaSB@UCI) – one of only 13 centers in the United States devoted to the promotion of interdisciplinary research among mathematicians, engineers, and biologists. At the national level, Dr. Waterman has served for many years as a grant reviewer for the National Institutes of Health, recently concluding her term as chair of an NIH cancer grant review panel. She is most proud of her service to the ACS as a reviewer and Chair of a grant review panel, and most recently as a member of the National Extramural Council for Grants.

Oscar B. Goodman, Jr. MD, PhD

Dr. Oscar Goodman is a physician-scientist. He is a hematologist, medical oncologist, and clinical researcher at Comprehensive Cancer Centers. Dr. Goodman also serves as an Associate Professor of Internal Medicine at Roseman University College of Medicine, where he conducts translational research with colleagues on the Prostate Cancer Research team as part of the university’s Cancer Research Program. His basic,translational, and clinical research projects center around understanding mechanisms that govern cancer’s resistance to hormonal therapy, focusing on prostate cancer.

Prior to joining Comprehensive Cancer Centers and Roseman in 2012, Dr. Goodman worked as a medical oncologist at the UC San Diego Nevada Cancer Institute. Before moving to Las Vegas, Dr. Goodman worked as a clinical associate and later as a physician for the Department of Medicine, Division of Hematology/Oncology, at New York Presbyterian Hospital, Weill Cornell Campus, in New York City.

Dr. Goodman has earned multiple awards during his extensive career. He is a recipient of the Young Investigator Award from the American Society of Clinical Oncology and has been named a Regional Top Doctor by US News and World Report and Castle-Connolly annually since 2008. Dr. Goodman has been honored with the title of Research Healthcare Headliner by Vegas Inc. and received the 2014 Southern Nevada Technology & Research Healthcare Hero award by Nevada Business Magazine. He was awarded the Inspired Excellence in Health Care Award by Las Vegas HEALS. Additionally, he is consistently recognized as a Top Doctor by Vegas Inc. and Desert Companion in its annual polls.

In addition to years of research and medical practice, Dr. Goodman has authored numerous abstracts, book chapters, and more than 40 peer-reviewed publications. He also received peer-reviewed translational research support through the Department of Defense.

Dr. Renee E. Coffman, BS Pharm, PhDPresident and Co-Founder

Dr. Renee Coffman is president and co-founder of the Nevada College of Pharmacy, now Roseman University of Health Sciences. She previously served as the University’s Executive Vice President for Quality Assurance and Intercampus Consistency and the Dean of its College of Pharmacy. Prior to establishing Roseman University, Dr. Coffman became a founding member of the faculty at Western University of Health Sciences, where she also held the position of Facilitative Officer for Student Services. While at Western, Dr. Coffman and four colleagues received Honorable Mention for the AACP Innovations in Teaching Awards.

A licensed pharmacist in the state of Nevada, Dr. Coffman earned a Pharmacy degree from Ohio Northern University in 1987 and following graduation worked as a pharmacist in her hometown of Bucyrus, Ohio and in Piqua, Ohio. In 1995, Dr. Coffman earned a doctoral degree in Industrial and Physical Pharmacy from Purdue University, where she received the Kienle Award for Excellence in Teaching, the Jenkins-Knevel Award for Outstanding Graduate Research and was awarded an AAPE-AFPE Association Fellowship in Pharmaceutical Sciences.